MyFinsight
Home
Blog
About
Property, plant and
equipment, gross
$297K
(6.07%↑ Y/Y)
Marketable securities
$38,375K
(48.00%↑ Y/Y)
Cash and cash
equivalents
$5,129K
(24.82%↑ Y/Y)
Prepaid expenses and
other assets
$567K
(-16.62%↓ Y/Y)
Amounts receivable
$244K
(51.55%↑ Y/Y)
Deferred offering costs
$400K
Operating lease
right-of-use asset
$153K
(-35.98%↓ Y/Y)
Property and equipment,
net
$133K
(-12.50%↓ Y/Y)
Less accumulated
depreciation
$164K
(28.13%↑ Y/Y)
Total current assets
$44,315K
(42.59%↑ Y/Y)
Total non-current
assets
$686K
(75.45%↑ Y/Y)
Total assets
$45,001K
(43.00%↑ Y/Y)
Total liabilities and
shareholders equity
$45,001K
(43.00%↑ Y/Y)
Total shareholders
equity
$38,338K
(41.10%↑ Y/Y)
Total current
liabilities
$6,594K
(60.20%↑ Y/Y)
Total non-current
liabilities
$69K
(-62.50%↓ Y/Y)
Accumulated deficit
-$192,949K
(-24.16%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$37K
(-164.29%↓ Y/Y)
Paid-in capital
$231,324K
(26.69%↑ Y/Y)
Accrued liabilities
$3,666K
(33.45%↑ Y/Y)
Accounts payable
$2,812K
(123.00%↑ Y/Y)
Operating lease
obligation
$107K
(11.46%↑ Y/Y)
Finance lease
obligation
$9K
(-25.00%↓ Y/Y)
Operating lease
obligation
$69K
(-60.80%↓ Y/Y)
Back
Back
Balance Sheet
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)
source: myfinsight.com